Social Media Ideas for Jnj

Latest updates for Jnj

Fresh curated links around JNJ are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Post angles to try

Share the most useful takeaway for your audience.

Turn one article into a quick practical checklist.

Ask your audience how this shift affects their work.

Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

seekingalpha.com /1 month ago

Johnson & Johnson (JNJ) Presents at Deutsche Bank 2026 Healthcare Summit Transcript

Read source

cafepharma.com /1 week ago

Welcome to JnJ

Welcome to JnJ Anonymous (not verified) Mon, 10/12/2026 - 07:11 field_thread_url https://cafepharma.com/boards/threads/welcome-to-jnj.705944/...

Read source

cafepharma.com /1 week ago

Welcome to JnJ

Welcome to JnJ Anonymous (not verified) Tue, 10/13/2026 - 07:11 field_thread_url https://cafepharma.com/boards/threads/welcome-to-jnj.705944/...

Read source

fool.com /1 week ago

Johnson & Johnson vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?

Johnson & Johnson trades at a higher valuation with growing sales, while Pfizer's dividend yield is near 6% as patents expire from 2026 through 2030.

Read source

webwire.com /1 month ago

Johnson & Johnson to Participate in the Deutsche Bank 2026 Healthcare Summit

Johnson & Johnson (NYSE: JNJ) will present at the Deutsche Bank 2026 Healthcare Summit on Thursday, September 17 th, 2026. Management will participate in a Fireside Chat at 12:...

Read source

fool.com /1 week ago

Johnson & Johnson: 3 Key Takeaways for Long-Term Investors

MedTech growth stalled while pharma surged, leaving the company to bet on new product launches and a planned spin-off to restore momentum.

Read source

fool.com /2 weeks ago

Prediction: Johnson & Johnson Will Be a Faster-Growing Company by 2030 Than Most Investors Expect

Don't underestimate this healthcare giant.

Read source

fool.com /1 month ago

Better Dividend King to Buy and Hold: Johnson & Johnson or Kenvue?

One healthcare dividend payer carries legal risk, the other faces a buyout. Here's which one actually deserves your money.

Read source

fool.com /1 month ago

I Think Johnson & Johnson Is the Best Dividend Stock to Buy Right Now

The company is firing on all cylinders.

Read source

fool.com /1 month ago

AbbVie vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?

AbbVie trades cheaper but carries heavy revenue concentration; Johnson & Johnson boasts a fortress balance sheet and wider portfolio.

Read source

fool.com /1 month ago

Johnson & Johnson May Offload Its Orthopedics Unit for $20 Billion -- and Investors Shouldn't Miss What That Could S...

Healthcare giant Johnson & Johnson is looking to become a more profitable and faster-growing business.

Read source

fool.com /2 weeks ago

Looking for a Dividend Stock That Can Weather a Downturn? Start With Johnson & Johnson.

Even in a recession, there's strong demand for J&J's myriad of pharmaceutical and healthcare products.

Read source

fool.com /1 month ago

Bristol Myers Squibb and Johnson & Johnson Both Face Challenges Ahead: Which Healthcare Stock Looks More Resilient N...

Bristol Myers Squibb trades at a steep valuation discount, while Johnson & Johnson's stronger margins and lower debt offer stability. But patent cliffs and litigation risks com...

Read source

fool.com /1 month ago

I Think Johnson & Johnson Is the Best Dividend Stock to Buy Right Now

Looking for a dividend stock you can sleep well owning? Here's why Johnson & Johnson could be the long-term healthcare anchor your portfolio needs.

Read source

investing.com /1 month ago

J&J orthopedics unit draws Apollo interest in potential $20 billion deal, Bloomberg News reports

Read source

fool.com /3 days ago

2 Dividend Stocks Crushing the Market in 2026 (and Which Ones Can Keep Going)

These drugmakers are facing some near-term challenges, but is that enough to stop their recent momentum?

Read source

fool.com /1 week ago

Should You Invest in This Dividend King on the Dip?

Looking beyond near-term headwinds paints a fairly bright picture of Johnson & Johnson’s outlook.

Read source

fool.com /1 week ago

Why Johnson & Johnson Stock Dropped Today

Johnson & Johnson beat earnings this morning. Then its stock price dropped.

Read source

law360.com /1 month ago

Sandoz Generic Would Infringe J&J Unit Patents, Judge Says

A New Jersey federal judge has ruled that Sandoz's attempt to manufacture a generic form of a Janssen Pharmaceuticals Inc. nasal spray would infringe a group of patents the Johnson...

Read source

biopharmadive.com /1 week ago

J&J earnings set ‘negative tone’; Shkreli vs. the FTC

A 6% sell-off in J&J shares was viewed by one analyst as emblematic of broader market volatility. Elsewhere, Gilead is collaborating with Vir and a biotech’s bid for a product...

Read source

cafepharma.com /1 month ago

JnJ Executive Committee Changes

JnJ Executive Committee Changes Anonymous (not verified) Sat, 09/05/2026 - 12:48 field_thread_url https://cafepharma.com/boards/threads/jnj-executive-commi...

Read source

fool.com /3 weeks ago

History Says Johnson & Johnson Beats Medtronic. Here's Why I'd Still Consider MDT for the Next Decade.

Medtronic is following a strategy that has worked well for Johnson & Johnson.

Read source

cafepharma.com /3 days ago

Divest BWI Now

Divest BWI Now Anonymous (not verified) Wed, 10/21/2026 - 13:15 field_thread_url https://cafepharma.com/boards/threads/divest-bwi-now.717817/...

Read source

cafepharma.com /3 weeks ago

Divest BWI Now

Divest BWI Now Anonymous (not verified) Tue, 09/29/2026 - 01:04 field_thread_url https://cafepharma.com/boards/threads/divest-bwi-now.717817/...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.